此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Postconditioning in ST-elevation Myocardial Infarction (POSTEMI)

2016年9月26日 更新者:Jan Eritsland、Oslo University Hospital

Postconditioning in ST-elevation Myocardial Infarction Treated With Primary PCI

Study objectives: To assess the effects of postconditioning on infarct size in patients with ST-elevation infarction referred to PCI.

Study design: Prospective, randomized, open-label study with blinded endpoint evaluation. Included patients will be randomly allocated to postconditioning or control. Patients with symptoms of acute myocardial infarction of less than 6 hours duration fulfilling ECG criteria for primary PCI are eligible. PCI follow established routines. In postconditioning patients, additional, short (1 min), intermittent balloon occlusions will be applied after initial opening of infarct related artery. After this intervention, PCI proceeds routinely with stent implantation. In the control group, stent implantation after initial opening proceeds as usual. Primary endpoint is final infarct size, determined by MRI after 4 months. 260 patients will be included. Follow-up is 1 year. Inclusion period: 18 - 24 months.

Clinical implications: Reperfusion therapy, administered as early as possible after start of symptoms, has improved the prognosis in acute ST-elevation myocardial infarction. Still, however, many patients suffer large infarctions, subsequently with an increased risk of heart failure, arrhythmias, and death. In pilot studies, mechanical postconditioning has been shown to reduce infarct size and thus potentially improve prognosis. However, the effect of postconditioning must be confirmed in larger clinical trials before implemented in routine treatment.

研究概览

研究类型

介入性

注册 (实际的)

272

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Oslo、挪威、N-0407
        • Dept. of Cardiology, Oslo Univ. Hosp. Ulleval

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • acute symptoms consistent with an acute myocardial infarction of less than 6 hours duration
  • an occluded infarct related artery must be demonstrated (TIMI-flow 0-1)

Exclusion Criteria:

  • Prior myocardial infarction
  • Demonstration of collaterals to the infarcted area
  • TIMI-flow >1 before intervention or TIMI-flow <2 after initial balloon inflation
  • Demonstration of a distal occlusion
  • Patients given thrombolytic treatment
  • Patients in cardiogenic shock
  • Any contraindication to MRI (magnetic resonance imaging)
  • Unwillingness to participate

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Postconditioning
Active arm:Postconditioning protocol before routine PCI/stenting of an occluded coronary artery
After opening of IRA and establishment of TIMI-flow grade 2 or 3, the control group continues the procedure with stenting. In the postconditioning group 4 additional balloon inflations separated by 1 minute reperfusion are given, starting after 1 minute of reperfusion.
其他:Control
Control arm: Routine PCI/stenting of an occluded coronary artery without postconditioning
After opening of IRA and establishment of TIMI-flow grade 2 or 3, the control group continues the procedure with stenting.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Infarct size, assessed by MRI
大体时间:4 months
4 months

次要结果测量

结果测量
措施说明
大体时间
Myocardial blushing grade
大体时间:assessed at the end of PCI procedure
assessed at the end of PCI procedure
ST-resolution in ECG
大体时间:Assessed after 1 hour
Assessed after 1 hour
Troponin-T and CK-MB
大体时间:peak release values
peak release values
Echocardiographic evaluation of left ventricular function including speckle-tracking measurement.
大体时间:assessed at baseline, 4 months and1 year
Assesment of LV function. Comparison with CMR in the whole study population and between treatment groups.
assessed at baseline, 4 months and1 year
Incidence of treated arrhythmias and heart failure during initial hospitalization Incidence of death, non-fatal myocardial infarction, unstable angina, heart failure, and cerebrovascular disease
大体时间:1-year follow up.
1-year follow up.
Myocardial salvage
大体时间:Baseline to 4 months
Myocardial salvage defined as (area at risk-final infarct size)/area at risk. Area at risk measured by CMR at baseline and final infarct size by CMR at 4 months.
Baseline to 4 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Jan Eritsland, MD, PhD、Oslo Univ.Hosp. Ulleval

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2009年6月1日

初级完成 (实际的)

2012年8月1日

研究完成 (实际的)

2013年8月1日

研究注册日期

首次提交

2009年6月16日

首先提交符合 QC 标准的

2009年6月16日

首次发布 (估计)

2009年6月17日

研究记录更新

最后更新发布 (估计)

2016年9月27日

上次提交的符合 QC 标准的更新

2016年9月26日

最后验证

2016年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅